PURPOSE: We described population level trends in radical prostatectomy for patients with prostate cancer by hospitals with robotic surgery, and assessed whether socioeconomic disparities exist in access to such hospitals.
MATERIALS AND METHODS: After merging the NIS (Nationwide Inpatient Sample) and the AHA (American Hospital Association) survey from 2006 to 2008, we identified 29,837 patients with prostate cancer who underwent radical prostatectomy. The primary outcome was treatment with radical prostatectomy at hospitals that have adopted robotic surgery. Multivariate logistic regression was used to identify patient and hospital characteristics associated with radical prostatectomy performed at hospitals with robotic surgery.
RESULTS: Overall 20,424 (68.5%) patients were surgically treated with radical prostatectomy at hospitals with robotic surgery, while 9,413 (31.5%) underwent radical prostatectomy at hospitals without robotic surgery. There was a marked increase in radical prostatectomy at hospital adopters from 55.8% in 2006 and 70.7% in 2007 to 76.1% in 2008 (p < 0.001 for trend). After adjusting for patient and hospital features, lower odds of undergoing radical prostatectomy at hospitals with robotic surgery were seen in black patients (OR 0.81, p < 0.001) and Hispanic patients (OR 0.77, p < 0.001) vs white patients. Compared to having private health insurance, being primarily insured with Medicaid (OR 0.70, p < 0.001) was also associated with lower odds of being treated at hospitals with robotic surgery.
CONCLUSIONS: Although there was a rapid shift of patients who underwent radical prostatectomy to hospitals with robotic surgery from 2006 to 2008, black and Hispanic patients or those primarily insured by Medicaid were less likely to undergo radical prostatectomy at such hospitals.
Written by:
Kim SP, Shah ND, Boorjian SA, Weight CJ, Tilburt JC, Han LC, Thompson RH, Trinh QD, Sun M, Moriarty JP, Karnes RJ. Are you the author?
Department of Urology, Mayo Clinic, Rochester.
Reference: J Urol. 2012 Dec 17. pii: S0022-5347(12)04845-8.
doi: 10.1016/j.juro.2012.09.033
PubMed Abstract
PMID: 23253307
UroToday.com Prostate Cancer Section
